The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ethyl 5-phenyl-1-(1-(3-(2,2,2-trifluoroacetamido)propyl)-1H-1,2,3-triazole-4-carbonyl)pyrrolidine-2-carboxylate ID: ALA4857252
PubChem CID: 164614683
Max Phase: Preclinical
Molecular Formula: C21H24F3N5O4
Molecular Weight: 467.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)C1CCC(c2ccccc2)N1C(=O)c1cn(CCCNC(=O)C(F)(F)F)nn1
Standard InChI: InChI=1S/C21H24F3N5O4/c1-2-33-19(31)17-10-9-16(14-7-4-3-5-8-14)29(17)18(30)15-13-28(27-26-15)12-6-11-25-20(32)21(22,23)24/h3-5,7-8,13,16-17H,2,6,9-12H2,1H3,(H,25,32)
Standard InChI Key: CDBJJPCFZVVCER-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 35 0 0 0 0 0 0 0 0999 V2000
18.3689 -7.5982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3677 -8.4177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0758 -8.8267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7854 -8.4173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7826 -7.5946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0740 -7.1893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0657 -6.3712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7254 -5.8889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4705 -5.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6533 -5.1149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4032 -5.8929 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6893 -6.2940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9864 -5.8772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6798 -7.1112 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.9107 -5.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1134 -4.8875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6966 -5.5905 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2363 -6.2040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1086 -4.0694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3985 -3.6650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6932 -4.0778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9831 -3.6734 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2778 -4.0861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5677 -3.6817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2826 -4.9033 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.5629 -2.8646 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.8624 -4.0945 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.5633 -4.4987 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.2382 -4.4038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6435 -3.6941 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4210 -4.4076 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4607 -3.6903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8659 -2.9807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 7 1 0
6 7 1 0
11 12 1 0
12 13 1 0
12 14 2 0
13 15 2 0
15 16 1 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
24 26 1 0
24 27 1 0
24 28 1 0
10 29 1 0
29 30 1 0
29 31 2 0
30 32 1 0
32 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 467.45Molecular Weight (Monoisotopic): 467.1780AlogP: 2.26#Rotatable Bonds: 8Polar Surface Area: 106.42Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.56CX Basic pKa: ┄CX LogP: 2.30CX LogD: 2.11Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.47Np Likeness Score: -1.39
References 1. Alam MM, Malebari AM, Syed N, Neamatallah T, Almalki ASA, Elhenawy AA, Obaid RJ, Alsharif MA.. (2021) Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells., 38 [PMID:33894490 ] [10.1016/j.bmc.2021.116136 ]